UNITED STATES Washington, D.C. 20549 | ||||
| ||||
FORM 8-K CURRENT REPORT | ||||
| ||||
PURSUANT TO SECTION 13 OR 15(d) OF THE | ||||
| December 11, 2025 |
| ||
(Date of Report (date of earliest event reported) | ||||
| ||||
IRIDEX CORPORATION | ||||
(Exact name of registrant as specified in its charter) | ||||
| ||||
Delaware | 000-27598 | 77-0210467 | ||
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer | ||
1212 Terra Bella Avenue | ||||
(Address of principal executive offices, including zip code) | ||||
| ||||
(650) 940-4700 | ||||
(Registrant’s telephone number, including area code) | ||||
(Former name or former address, if changed since last report) | ||||
| ||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): | ||||
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
| ||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||||
Emerging growth company ☐ | ||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ | ||||
Securities registered pursuant to Section 12(b) of the Act:
Title of Class |
| Trading Symbol |
| Name of Exchange on Which Registered |
Common Stock, par value $0.01 per share |
| IRIX |
| Nasdaq Capital Market |
Item 7.01. Regulation FD Disclosure.
As previously announced, IRIDEX Corporation (the “Company”) is participating in the Sidoti Year-End Virtual Investor Conference to be held on December 11, 2025.A live webcast of the event will begin at 10:45 a.m. ET and will be accessible at that time and as an archived webcast on the investors section of the Company’s website at www.IRIDEX.com.
The Company is also furnishing presentation materials included as Exhibit 99.1 to this report pursuant to Item 7.01 of Form 8-K. The Company is not undertaking to update this presentation. The information in this report (including Exhibits 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibits 99.1).
Item 9.01. Financial Statements and Exhibits.
|
|
(d) | Exhibits |
Exhibit No. |
| Description |
|
| |
99.1 |
| |
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document). |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
| IRIDEX CORPORATION |
|
|
|
|
| By: |
| /s/PATRICK MERCER |
|
|
| Patrick Mercer |
|
|
| Chief Executive Officer |
|
|
|
|
Date: December 11, 2025 |
|
|
|
-3-